Valuation: Abbott Laboratories

Market Cap 202B 1,041B 173B 162B 148B 278B 19,311B 282B 1,911B 745B 9,701B 758B 741B 32,086B P/E 2026 *
33.5x
P/E 2027 * 25.8x
Enterprise Value 226B 1,165B 193B 181B 166B 311B 21,602B 315B 2,138B 834B 10,851B 848B 829B 35,892B EV / Sales 2026 *
4.49x
EV / Sales 2027 * 4.08x
Free-Float
86.16%
Yield 2026 *
2.2%
Yield 2027 * 2.35%
1 day+4.19%
1 week+2.81%
Current month+11.02%
1 month+16.46%
3 months+36.34%
6 months+2.30%
Current year-13.27%
1 week 46.64
Extreme 46.64
49.95
1 month 42.44
Extreme 42.44
49.95
Current year 33.5
Extreme 33.5
57.5
1 year 33.5
Extreme 33.5
61.82
3 years 33.5
Extreme 33.5
67.65
5 years 33.5
Extreme 33.5
67.65
10 years 10.4
Extreme 10.403333
67.65
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
+4.19%+2.81% - - 202B
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average +1.66%+0.28%+9.51%+16.66% 66.7B
Weighted average by Cap. +2.20%+1.90%+1.97%+17.88%

Financials

2026 *2027 *
Net sales 50.3B 260B 43.09B 40.32B 36.91B 69.26B 4,813B 70.18B 476B 186B 2,418B 189B 185B 7,997B 54.65B 282B 46.81B 43.8B 40.09B 75.24B 5,228B 76.24B 517B 202B 2,626B 205B 201B 8,687B
Net income 6.23B 32.16B 5.34B 5B 4.57B 8.58B 596B 8.69B 59.02B 23.01B 300B 23.4B 22.89B 991B 7.92B 40.89B 6.79B 6.35B 5.81B 10.91B 758B 11.06B 75.04B 29.26B 381B 29.76B 29.11B 1,260B
Net Debt 23.94B 124B 20.51B 19.19B 17.56B 32.96B 2,290B 33.4B 227B 88.4B 1,151B 89.89B 87.93B 3,806B 20.96B 108B 17.95B 16.8B 15.38B 28.86B 2,005B 29.24B 198B 77.39B 1,007B 78.69B 76.98B 3,332B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
21/08/26 R$49.75 +0.81% 216
20/08/26 R$49.35 +0.20% 593
19/08/26 R$49.25 +0.41% 197
18/08/26 R$49.05 +3.05% 373
17/08/26 R$47.60 -1.63% 588
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.64USD
Average target price
120.20USD
Spread / Average Target
+3.05%

Quarterly revenue - Rate of surprise